Metrics as of 10/13/2026, 10:55 AM (Berlin time), refresh in progress.
BioNTech Stock
BioNTech SE
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Germany
- CEO
- Ugur Sahin
- Employees
- 7,807
- Market cap
- $22.7 B
- IPO
- 10/10/2019
BioNTech SE is a biotechnology company headquartered in Mainz, Germany. Established in 2008, the firm operates within the healthcare sector, specializing in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. Its broader scope encompasses preventative vaccines for…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
BioNTech stock: price history
1D
-5.8%
1W
-5.7%
1M
-6.7%
6M
-8.3%
YTD
-5.2%
1Y
-11.7%
2Y
-25.1%
5Y
-63.3%
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~2% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about BioNTech
Analyst assessment of BioNTech
PRICE TARGET LOW
US$96.00
CONSENSUS
US$121.00
MEDIAN
US$124.50
PRICE TARGET HIGH
US$140.00
0
STRONG BUY
20
BUY
4
HOLD
0
SELL
0
STRONG SELL
24
TOTAL · Buy
As of: 07/10/2026
BioNTech stock metrics
P/E
-12.03
P/B
1.16
EV/EBITDA
-13.11
RETURN ON EQUITY
-4.6%
NET MARGIN
-777.3%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
250,268,880
AVG. DAILY VOLUME (30D)
923,921
Insider transactions (SEC)
Sahin Ugur
Sahin Ugur
Sahin Ugur
Sahin Ugur
Sahin Ugur
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.8%
Forums (Reddit)
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about BioNTech stock
What does BioNTech do?
BioNTech SE is a company in the Healthcare sector, Biotechnology industry, headquartered in Germany.
The CEO is Ugur Sahin, the company employs around 7,807 people.
The IPO was on 10/10/2019; the stock trades on NASDAQ under the ticker BNTX.
What do analysts say about BioNTech stock?
24 analysts rate the stock, the consensus is Buy (as of 07/10/2026).
The average price target is US$121.00, ranging from US$96.00 to US$140.00, with a median of US$124.50.
This is an external assessment, not a statement by Market Jury.
When does BioNTech report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 2% stronger than usual.
Does BioNTech pay a dividend?
Yes. The last dividend was US$2.11 per share, ex-date 02/06/2022, paid on 17/06/2022.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to BioNTech?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get BioNTech stock analyzed?
Clicking "Analyze stock" lets five strategies assess BioNTech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.